AzTrials
AzTrials

Hand InjuriesIASTMNCT07009197

Effect of Instrument Assisted Soft Tissue Mobilization on Hand Post Surgical Scars in Primary Flexor Tendons Repair in Zone v

A study testing Instrument Assisted Soft Tissue Mobilization and traditional therapy in people with Hand Injuries, run by Cairo University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

this study will be conducted to investigate the effect of instrument assisted soft tissue mobilization on hand post surgical scars in primary flexor tendons repair in zone v Read more about this study

Who is it for?
Ages 20 to 40 years
Conditions the study is for
Hand Injuries
What is being tested?
Instrument Assisted Soft Tissue Mobilization and traditional therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
42 participants
Where
No sites listed yet
Study dates
5 Jun 2025to 1 Sep 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Both sex will be included in this research
  • Hand scar in zone v
  • Age varying from 20 to 40
  • Hand scar formed post primary flexor tendons repair

Who cannot join

  • Vascular injuries requiring arterial repair
  • Soft tissue loss
  • Fractures
  • Tendon in-juries of other zones
  • Preexisting problems such as arthritis limiting joint motion
  • unhealed wounds or age of scar under 6 weeks

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

alzahraa labib, master contact

01010602832

zhraalabib214@yahoo.com

About this study

this study will be conducted to investigate the effect of instrument assisted soft tissue mobilization on hand post surgical scars in primary flexor tendons repair in zone v

Read the detailed description

The hand plays an important role in independent daily living and in communication with the environment. As the most mobile part of the upper extremity, the hand is actively used in everyday life and professional fields. The flexor tendons of the hand are critical for normal hand function. Injury to these tendons can result in absent finger and wrist flexion, and a subsequent loss of overall hand function. The surgical techniques used to repair these tendons have improved in the past few decades, as have the postoperative rehabilitation protocols. In spite of these advances, flexor tendon repairs continue to be plagued by postoperative scar formation, which limits tendon gliding and prevents a full functional recovery. Many different treatment methods can reduce the trauma and surgical scars. Manual scar treatment is one of these methods. Manual scar therapy to be effective requires applying physiological stimuli adequately to the phase of wound healing. Scar tissue therapy is a treatment for reducing pain and functional limitations, improving pliability, reducing hyper-pigmentation, pruritus, fascial adhesions, to reduce scar thickness and smooth surface area. Instrument assisted soft tissue mobilization (IASTM) is a soft-tissue treatment technique where an instrument is used to provide a mobilizing stimulus to positively affect scar tissue and myofascial adhesion.

Conditions
Hand Injuries
Being tested
Instrument Assisted Soft Tissue Mobilization, traditional therapy
Keywords
Instrument Assisted Soft Tissue Mobilization, Primary Flexor Tendons Repair, Hand Post Surgical Scars
Medical subject headings
Hand Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Instrument Assisted Soft Tissue MobilizationOther

    the treatment will start by disinfect the instrument between patients to avoid transfer of infections. It is recommended to disinfect the instrument with intermediate-level disinfectants (e.g. isopropyl alcohol), then wash it with soap and water to remove any residuals of the chemical disinfectant off the instrument. If the tools contacts blood, bodily fluids, mucous membranes, or non-intact skin then disinfecting it with high-level disinfectant should be done .IASTM will be done at 30-60 degrees angle for 40-120 seconds+ radiational therapy

  • traditional therapyOther

    the patients will receive traditional therapy in the form of ultrasound, scar massage, and stretching exercises.

Study groups in NCT07009197
Study groupRoleWhat they receive
Instrument Assisted Soft Tissue MobilizationExperimentalTwenty-one patients will receive instrument-assisted soft tissue mobilization and traditional therapy three times a week for four weeks.
Receives: Other: Instrument Assisted Soft Tissue Mobilization; Other: traditional therapy
traditional therapyActive comparatorTwenty-one patients will receive traditional therapy three times a week for four weeks.
Receives: Other: traditional therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. scar assessment

    Patient and Observer Scar Assessment Scale (POSAS) will be used to assess scar.It consists of two distinct scales: the OSAS and the PSAS. The PSAS consists of six items: scar-related pain, itchiness, colour, stiffness, thickness and irregularity. Each POSAS item has a 10-point scoring system, with 1 representing normal skin and 10 the worst imaginable scar or sensation; these items are summed to obtain a total score ranging from 6 to 60 for each scale. In addition to the POSAS score, both observer and patient give their own overall opinion on the appearance of the scar using a 10-point scale.

    Measured: up to four weeks

Secondary outcomes (2)
  1. range of motion

    the range of motion (wrist, metacarpophalangeal, proximal and disatal interphalangeal joint)will be assessed by kinovea software.Kinovea provides a tool to manually draw lines and measure angles to assess ROM as the following:Pause the video at the point where maximum movement occurs (e.g., maximum wrist flexion).Use the angle tool to draw two lines corresponding to the bones of the joint. The software will calculate the angle between the lines, giving you a measure of the ROM.

    Measured: up to four weeks

  2. handgrip strength

    The hand dynamometer will be used to assess hand grip strength.The subject grips the dynamometer with their maximum force for a few seconds (typically 3 to 5 seconds).Avoid jerky movements or changes in posture during the measurement.

    Measured: up to four weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jun 2025
  2. Study start5 Jun 2025 (estimated)
  3. Primary completion1 Sep 2025 (estimated)
  4. Study completion1 Sep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
instrumented assisted soft tissue mobilization and tradional therapy
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
42 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07009197
Sponsor's protocol ID
P.T.REC/012/005611
Acronym
IASTM
Status last verified
May 2025
First submitted
29 May 2025
Last updated
6 Jun 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Instrument Assisted Soft Tissue Mobilization and traditional therapy in people with Hand Injuries, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 6 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact alzahraa labib, master (01010602832, zhraalabib214@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

scar assessment (time frame: up to four weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in